排序方式: 共有58条查询结果,搜索用时 0 毫秒
1.
2.
分水岭脑梗死是临床脑梗死中的常见类型。随着人们对于分水岭脑梗死研究的进一步加深,分水岭脑梗死的中医药研究方面同时也取得了很大的进展。此文尝试从分水岭脑梗死的中医病因病机、体质分型、辨证论治、中成药的治疗、针灸治疗等方面对分水岭脑梗死的中医药研究进展进行综合论述,为分水岭脑梗死的临床治疗提供理论依据。 相似文献
3.
4.
5.
中风病是临床的常见病、多发病。本病病因较多,病情变化迅速,证型繁杂,不同的文献中证候分类差异较大。证候分类的繁杂给临床工作者治疗中风病带来极大不便。本文对以证候要素(内风、内火、痰湿、瘀血、气虚、阴虚)为切入点论治中风病的理论进行探讨,并举例论证其临床疗效。 相似文献
6.
难治性癫痫(RE)病机复杂,易于反复,朱文浩主任医师注重情志内伤对RE患者体质的影响,在治疗上重视“脏气不平”这一发病基础,从“气郁血瘀”角度分析,以血府逐瘀汤为基础方进行治疗,临床上取得满意疗效。该文选取2则医案进行深入分析。 相似文献
7.
丝裂原活化蛋白激酶1/2(ERK1/2)通路是第一个被发现的细胞信号转导通路,由Ras、Raf、MEK1/2和ERK1/2组成。ERK1/2通路激活后可以将细胞外信号从细胞膜转到细胞核,参与了细胞的多种生理病理功能,如细胞的生长、增殖、分化和凋亡等,并且与多种疾病的发病有关,包括多发性硬化(MS)和实验性自身免疫性脑脊髓炎(EAE)。ERK1/2通路的激活可以引起星形胶质细胞、MG、T细胞、巨噬细胞等活化,释放多种炎性因子,引起髓鞘损伤,导致MS/EAE的发病。多项研究表明,通过抑制ERK1/2通路可以减少炎性因子的释放,减轻髓鞘损伤,改善MS/EAE的病情,为治疗MS药物的开发提供了重要的靶点。 相似文献
8.
目的探讨吸烟与中风病中医证候的相关性。方法制定调查表,由临床中医师采集中风病患者的临床资料并辨证,然后双人、双盲录入到数据库,导出数据后统计分析。将中风病患者分为吸烟组和非吸烟组,分别对两组的中医证候进行统计分析。结果吸烟组中风病患者年龄(64.7±0.7)岁,小于非吸烟组(69.5±0.5)岁,吸烟组中风病患者风痰阻络证的比例(61.4%),高于非吸烟组(51.9%)。结论吸烟使中风病的发病年龄提前,与中风病风痰阻络证的形成有关。 相似文献
9.
The study aimed to investigate the impact of intraclot recombinant tissue-type plasminogen activator (rt-PA) on perihematomal edema (PHE) development in patients with intracerebral hemorrhage (ICH) treated with minimally invasive surgery (MIS) and the effects of intraclot rt-PA on the 30-day survival. We reviewed the medical records of ICH patients undergoing MIS between October 2011 and July 2013. A volumetric analysis was done to assess the change in PHE and ICH volumes at pre-MIS (T1), post-MIS (T2) and day 10-16 (T3) following diagnostic computed tomographic scans (To). Forty-three patients aged 52.8±11.1 years with (n=30) or without rt-PA (n=13) were enrolled from our institutional ICH database. The median rt-PA dose was 1.5 (1) mg, with a maximum dose of 4.0 mg. The ratio of clot evacuation was significantly increased by intraclot rt-PA as compared with controls (77.9%±20.4% vs. 64%±15%; P=0.046). From TI to T2, reduction in PHE volume was strongly associ- ated with the percentage of clot evacuation (p=0.34; P=-0.027). In addition, PHE volume was positively correlated with residual ICH volume at the same day (p ranging from 0.39-0.56, P〈0.01). There was no correlation between the cumulative dose of rt-PA and early (T2) PHE volume (p=0.24; P=0.12) or de- layed (T3) PHE volume (p=0.19; P=0.16). The 30-day mortality was zero in this cohort. In the selected cohort of ICH patients treated with MIS, intraclot rt-PA accelerated clot removal and had no effects on PHE formation. MIS aspiration and low dose of rt-PA seemed to be feasible to reduce the 30-day mor- tality in patients with severe ICH. A large, randomized study addressing dose titration and long-term outcome is needed. 相似文献
10.
目的:了解脑出血微创血肿抽吸引流术(微创术)后颅内积气的发生情况。方法:接受微创术治疗的脑出血患者134例,术后出现颅内积气的患者为A组(n=97),未出现颅内积气的病例为B组(n=37)。对2组的临床数据进行统计分析。结果:A组中双针穿刺比例、血肿抽吸量及引流量与B组比较差异有统计学意义(P<0.05)。Logistic回归分析表明,双针穿刺是影响术后颅内积气及其严重程度的独立危险因素。结论:脑出血微创血肿抽吸引流术后常出现颅内积气,但对患者预后无显著影响。双针穿刺可能增加术后颅内积气的风险。 相似文献